Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prodromal Alzheimer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04867616
What this trial is testing

Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
UCB Biopharma SRL 466
Testing effectiveness (Phase 2)Active Not RecruitingNCT06402838
What this trial is testing

Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Hoffmann-La Roche 256
Not applicableStudy completedNCT03249688
What this trial is testing

Multimodal Preventive Trial for Alzheimer's Disease

Who this might be right for
Alzheimer Disease; Prodromal
Karolinska Institutet 93
Large-scale testing (Phase 3)Ended earlyNCT03444870
What this trial is testing

Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Who this might be right for
Alzheimer Disease
Hoffmann-La Roche 1,053
Not applicableStudy completedNCT03834402
What this trial is testing

INTERCEPTOR Project: From MCI to Dementia

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
Catholic University of the Sacred Heart 500
Large-scale testing (Phase 3)Ended earlyNCT02760602
What this trial is testing

Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 26
Large-scale testing (Phase 3)Study completedNCT03486938
What this trial is testing

Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentProdromal Alzheimer's Disease
AgeneBio 164
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07167966
What this trial is testing

Alzheimer's Tau Platform: Regimen A - AADvac1

Who this might be right for
Preclinical Alzheimer's DiseaseProdromal Alzheimer's DiseaseAlzheimer Disease
Paul S. Aisen 450
Not applicableLooking for participantsNCT06869135
What this trial is testing

Saliva and Extracellular Vesicles for Neurodegenerative Diseases

Who this might be right for
Neurodegenerative DiseasesParkinson DiseaseAlzheimer Disease+3 more
Fondazione Don Carlo Gnocchi ETS 242
Large-scale testing (Phase 3)Ended earlyNCT01953601
What this trial is testing

Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)

Who this might be right for
Amnestic Mild Cognitive ImpairmentAlzheimer's DiseaseProdromal Alzheimer's Disease
Merck Sharp & Dohme LLC 1,454
Large-scale testing (Phase 3)Study completedNCT01224106
What this trial is testing

Gantenerumab in Participants With Prodromal Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Hoffmann-La Roche 799
Not applicableStudy completedNCT04004767
What this trial is testing

TRC-PAD Program: In-Clinic Trial-Ready Cohort

Who this might be right for
Preclinical Alzheimer's DiseaseProdromal Alzheimer's DiseaseAlzheimer Disease+1 more
University of Southern California 220
Early research (Phase 1)Study completedNCT02127476
What this trial is testing

Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Kyowa Kirin Co., Ltd. 57
Testing effectiveness (Phase 2)WithdrawnNCT05986721
What this trial is testing

Clinical Trial of AGB101 for Mild Cognitive Impairment

Who this might be right for
Mild Cognitive ImpairmentProdromal Alzheimer's Disease
AgeneBio
Testing effectiveness (Phase 2)Looking for participantsNCT07477431
What this trial is testing

Levetiracetam for Persons at Risk for Alzheimer's Disease

Who this might be right for
Hippocampal HyperactivationProdromal Alzheimer Disease
Sunnybrook Health Sciences Centre 40
Testing effectiveness (Phase 2)Ended earlyNCT03289143
What this trial is testing

Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 457
Not applicableLooking for participantsNCT05934188
What this trial is testing

Exploring the Gut-Brain Axis in Ageing and Neurodegeneration

Who this might be right for
HealthyProdromal Alzheimer's DiseaseParkinson Disease+1 more
IRCCS San Camillo, Venezia, Italy 200
Not applicableStudy completedNCT04265378
What this trial is testing

Cognitive Training and Brain Stimulation in Prodromal Alzheimer's Disease

Who this might be right for
Subjective Cognitive DeclineMild Cognitive Impairment
University Medicine Greifswald 46
Testing effectiveness (Phase 2)Looking for participantsNCT06957418
What this trial is testing

Alzheimer's Tau Platform: Master Protocol

Who this might be right for
Preclinical Alzheimer's DiseaseAlzheimer DiseaseProdromal Alzheimer's Disease
Paul S. Aisen 900
Not applicableUnknownNCT03138018
What this trial is testing

Aging Stereotypes and Prodromal Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment (MCI)
Assistance Publique Hopitaux De Marseille 260
Next Page